The problem with testosterone cypionate discussion is that the anecdote and the mechanism get merged. Here is my attempt to keep them apart.
What surprised me is how much of the perceived benefit was routine and attention rather than pharmacology.
Baseline first. Without a baseline the after picture is decoration.
Sample size, blinding, and who paid for it. Those three questions kill most of the confidence in most of these threads.
Haematocrit creep is the boring one that catches people at the six week mark.
Where does the human data stop and the extrapolation start?
Read methods.
Test one thing at a time. It feels slower and it is the only way to learn anything.
I would take the narrow conclusion. Broad ones are more interesting and less true.